Company · CIK 1477845
Annovis Bio, Inc.
| CIK | 1477845 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | ANVS (NYSE) |
| First annual or quarterly report | 2020-03-25 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276814 | 2024-02-01 | 2026-05-20 | 14 | |
| 333-252625 | 2021-02-01 | 2023-11-01 | 7 | |
| 333-232529 | 2019-07-03 | 2020-01-30 | 9 |
Filings
31| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-20 | 424B5Shelf takedown | 333-276814 | 0001104659-26-064510 |
| 2026-05-19 | 424B5Shelf takedown | 333-276814 | 0001104659-26-063959 |
| 2026-04-09 | 424B5Shelf takedown | 333-276814 | 0001104659-26-041561 |
| 2025-10-28 | 424B5Shelf takedown | 333-276814 | 0001104659-25-103093 |
| 2025-10-14 | 424B5Shelf takedown | 333-276814 | 0001104659-25-099237 |
| 2025-02-04 | 424B5Shelf takedown | 333-276814 | 0001104659-25-008809 |
| 2025-02-03 | 424B5Shelf takedown | 333-276814 | 0001104659-25-008278 |
| 2024-12-11 | 424B5Shelf takedown | 333-276814 | 0001104659-24-127434 |
| 2024-05-01 | 424B5Shelf takedown | 333-276814 | 0001104659-24-055770 |
| 2024-03-22 | 424B5Shelf takedown | 333-276814 | 0001104659-24-037418 |
| 2024-03-19 | 424B5Shelf takedown | 333-276814 | 0001104659-24-035777 |
| 2024-03-19 | 424B5Shelf takedown | 333-276814 | 0001104659-24-035746 |
| 2024-02-12 | EFFECTDeclared effective | 333-276814 | 9999999995-24-000393 |
| 2024-02-01 | S-3Shelf registered | 333-276814 | 0001104659-24-009446 |
| 2023-11-01 | 424B5Shelf takedown | 333-252625 | 0001104659-23-113277 |
| 2023-10-30 | 424B5Shelf takedown | 333-252625 | 0001104659-23-112646 |
| 2023-03-31 | 424B5Shelf takedown | 333-252625 | 0001104659-23-040298 |
| 2021-05-24 | 424B4Final prospectus | 333-252625 | 0001104659-21-071362 |
| 2021-05-21 | 424B4Final prospectus | 333-252625 | 0001104659-21-070551 |
| 2021-02-11 | EFFECTDeclared effective | 333-252625 | 9999999995-21-000612 |
| 2021-02-01 | S-3Shelf registered | 333-252625 | 0001104659-21-010314 |
| 2020-01-30 | 424B4Final prospectus | 333-232529 | 0001047469-20-000594 |
| 2020-01-28 | EFFECTDeclared effective | 333-232529 | 9999999995-20-000171 |
| 2020-01-24 | S-1/AAmendment | 333-232529 | 0001047469-20-000480 |
| 2020-01-21 | S-1/AAmendment | 333-232529 | 0001047469-20-000329 |
| 2019-11-19 | S-1/AAmendment | 333-232529 | 0001047469-19-006396 |
| 2019-09-20 | S-1/AAmendment | 333-232529 | 0001047469-19-005362 |
| 2019-08-28 | S-1/AAmendment | 333-232529 | 0001047469-19-004854 |
| 2019-08-08 | S-1/AAmendment | 333-232529 | 0001047469-19-004651 |
| 2019-07-03 | S-1Registration filed | 333-232529 | 0001047469-19-003982 |
| 2019-05-15 | DRSDraft made public | 377-02651 | 0000912057-19-000217 |